Neuromodulation of Brain and Emotional Responses to Psychological Stress
NUMBER
2 other identifiers
interventional
55
1 country
1
Brief Summary
Investigators are conducting this study to test if temporarily and non-invasively stimulating the brain will affect the emotional response to stress in healthy participants. Participants will perform a series of tasks while completing an MRI scan. After this, participants will be randomized to undergo transcranial magnetic stimulation (TMS) at two visits, undergoing active stimulation at one visit and undergoing 'sham' stimulation at another visit. Immediately following both stimulation sessions, participants will repeat the tasks during MRI scanning.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable healthy
Started Apr 2025
Longer than P75 for not_applicable healthy
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
September 16, 2024
CompletedFirst Posted
Study publicly available on registry
September 19, 2024
CompletedStudy Start
First participant enrolled
April 9, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2028
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 1, 2029
May 6, 2026
May 1, 2026
3.2 years
September 16, 2024
May 1, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (7)
Dorsal anterior cingulate cortex activation to stress
Blood-oxygen-level-dependent (BOLD) signal in a dorsal anterior cingulate cortex (dACC) region of interest mask extracted from the incongruent (stress) vs congruent (control) contrast.
30-60 mins post-stimulation
Dorsal anterior cingulate cortex connectivity to stress
Generalized psychophysiological interaction (gPPI) estimate reflecting stressor-evoked dorsal anterior cingulate cortex (dACC) functional connectivity to the anterior insula, amygdala, and periaqueductal gray.
30-60 mins post-stimulation
Change in arousal during stress
Rating on a modified self-assessment manikin scale (SAM) measuring subjective ratings of arousal ("To what extent do you feel calm?" 1 - very calm, 9 - very aroused) following the psychological stressor task compared to a pre-stressor baseline.
30-60 mins post-stimulation
Change in valence during stress
Rating on a modified self-assessment manikin scale (SAM) measuring subjective ratings of valence ("To what extent do you feel happy vs unhappy?" 1 - very unhappy, 9 - very unhappy) following the psychological stressor task compared to a pre-stressor baseline.
30-60 mins post-stimulation
Change in perceived control during stress
Rating on a modified self-assessment manikin scale (SAM) measuring subjective ratings of perceived control ("To what extent do you feel in control?" 1 - very little control, 9 - very much control) following the psychological stressor task compared to a pre-stressor baseline.
30-60 mins post-stimulation
Systolic blood pressure response to stress
The difference in systolic blood pressure (in mmHg) obtained during the psychological stress task compared to a resting pre-stressor period.
30-60 mins post-stimulation
Heart rate response to stress
The difference in heart rate (in beats per minute) obtained during the psychological stress task compared to a resting pre-stressor period.
30-60 mins post-stimulation
Secondary Outcomes (2)
Dorsal anterior cingulate cortex (dACC) resting cerebral blood flow (rCBF)
30-60 mins post-stimulation
Positive and Negative Affect Schedule - Expanded Form (PANAS-X)
30-60 mins post-stimulation
Study Arms (2)
Active then Sham
EXPERIMENTALIn this arm, participants will first undergo active theta burst stimulation (cTBS) at the first visit and then undergo sham cTBS in the second visit.
Sham then Active
EXPERIMENTALIn this arm, participants will first undergo sham theta burst stimulation (cTBS) at the first visit and then undergo active cTBS in the second visit.
Interventions
This intervention involves an active form of continuous theta burst stimulation (cTBS) that will be targeted to the dorsal anterior cingulate cortex based on neural navigation software. cTBS will be delivered in one session, lasting a few minutes, before participants complete additional testing.
This intervention involves an sham form of continuous theta burst stimulation (cTBS) that will be targeted to the dorsal anterior cingulate cortex based on neural navigation software. cTBS will be delivered in one session, lasting a few minutes, before participants complete additional testing.
Eligibility Criteria
You may not qualify if:
- e. A person who reports that he or she was once on a disallowed medication but has discontinued this medication for at least a month or longer and is otherwise eligible, is allowed to participate in the study.
- Anyone reporting 35 or more alcoholic drinks in the last 7 days is excluded.
- Anyone reporting consumption of 6 or more alcoholic drinks on 3 or more occasions in the past 7 days is excluded.
- Anyone reporting use of illicit drugs on 7 or more days in the past 2 weeks is excluded.
- Medical conditions:
- Epilepsy or a history of seizures.
- Self-reported prior heart attack, stroke, bypass surgery, angioplasty, congestive heart failure, arrhythmia (cardiac rhythm problems).
- Severe hypertension (SBP/DBP \> 160/and/or \>100 mmHg)
- Cancer (treatment in last 12 months, allowances for non-melanoma skin cancer)
- Liver disease
- Kidney disease
- Type I diabetes
- Self-reported history of a major neurological disorder or brain injury resulting in ongoing symptoms or cognitive impairment (e.g., multiple sclerosis, cerebral palsy, major head injury)
- Self-reported chronic psychotic illness (schizophrenia, bipolar disorder)
- Pregnant participants, or participants actively planning to become pregnant in the next 3 months, are excluded.
- +8 more criteria
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, 15213, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Thomas E Kraynak, PhD
University of Pittsburgh
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR
- Masking Details
- Participants, study staff, and the principal investigator will be blinded (masked) to participant assignment. The TMS coil to be used for this study is specifically designed to ensure participant and study staff blinding to condition.
- Purpose
- BASIC SCIENCE
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
September 16, 2024
First Posted
September 19, 2024
Study Start
April 9, 2025
Primary Completion (Estimated)
July 1, 2028
Study Completion (Estimated)
July 1, 2029
Last Updated
May 6, 2026
Record last verified: 2026-05
Data Sharing
- IPD Sharing
- Will share
We will comply with all National Institute of Mental Health (NIMH) guidelines regarding data sharing and make use of NIMH databases.